Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.39 |
| ▸ | MGLL | Q99685 | 3/20 | 0.39 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.36 |
| ▸ | TUBB | P07437 | 1/20 | 0.36 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.36 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.36 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.36 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.36 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.36 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.36 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.36 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.36 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.36 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.36 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.36 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.36 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL757020 | 0.83 | FAAH (0.36) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL18392721 | 0.82 | FAAH (0.39) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL798141 | 0.81 | FAAH (0.41) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL22898718 | 0.78 | ALDH1A1 (0.38) | FAAHMGLLALDH1A1MEN1KMT2A | |
| SCHEMBL15998529 | 0.78 | FAAH (0.34) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL1984416 | 0.78 | TUBB4A (0.38) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL20626659 | 0.77 | FAAH (0.45) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL8448754 | 0.77 | FAAH (0.47) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL15862647 | 0.77 | FAAH (0.39) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL15697618 | 0.77 | FAAH (0.39) | FAAHMGLLTUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024146945-A1 | NOVEL CARBOXAMIDE AND SULFONAMIDE PESTICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024126650-A1 | NOVEL BICYCLIC-CARBOXAMIDE COMPOUNDS USEFUL AS PESTICIDES | SYNGENTA CROP PROTECTION AG (CH) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024115512-A1 | MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024115509-A1 | MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024105104-A1 | MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2024-05-23 | — | — | WO | disclosed |
| US-11857605-B2 | Thiosuccinyl-crosslinked hemoglobin conjugates and methods of use and preparation thereof | BILLION KING INTERNATIONAL LIMITED (CN) | 2024-01-02 | — | — | US | disclosed |
| US-11857605-B2 | Thiosuccinyl-crosslinked hemoglobin conjugates and methods of use and preparation thereof | BILLION KING INTERNATIONAL LIMITED (CN) | 2024-01-02 | — | — | US | disclosed |
| WO-2023217989-A1 | ALKOXY HETEROARYL- CARBOXAMIDE OR THIOAMIDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2023-11-16 | — | — | WO | disclosed |
| US-11692022-B2 | Thiosuccinyl-crosslinked hemoglobin analogs and methods of use and preparation thereof | BILLION KING INTERNATIONAL LIMITED (CN) | 2023-07-04 | — | — | US | disclosed |
| US-11692022-B2 | Thiosuccinyl-crosslinked hemoglobin analogs and methods of use and preparation thereof | BILLION KING INTERNATIONAL LIMITED (CN) | 2023-07-04 | — | — | US | disclosed |
| US-20210395309-A1 | PEPTIDE-DRUG CONJUGATES | HONG KONG BAPTIST UNIVERSITY (CN) | 2021-12-23 | — | — | US | disclosed |
| WO-2021013131-A1 | HEMOGLOBIN-BASED THERAPEUTIC AGENTS | Cheer Global Limited (CN) | 2021-01-28 | — | — | WO | disclosed |
| US-20210015935-A1 | HEMOGLOBIN-BASED THERAPEUTIC AGENTS | Cheer Global Limited (HK) | 2021-01-21 | — | — | US | disclosed |
| WO-2020239855-A1 | MICROBIOCIDAL DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2020-12-03 | — | — | WO | disclosed |
| WO-2017134547-A1 | TUBULYSIN ANALOGS AND METHODS FOR THEIR PREPARATION | PFIZER INC. (US) | 2017-08-10 | — | — | WO | disclosed |
| US-20170014520-A1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | GENZYME CORPORATION | 2017-01-19 | — | — | US | disclosed |
| US-9469850-B2 | Oligosaccharides comprising an aminooxy group and conjugates thereof | GENZYME CORPORATION (US) | 2016-10-18 | — | — | US | disclosed |
| US-20150050262-A1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | GENZYME CORPORATION (US) | 2015-02-19 | — | — | US | disclosed |
| US-8759501-B2 | Oligosaccharides comprising an aminooxy group and conjugates thereof | GENZYME CORPORATION (US) | 2014-06-24 | — | — | US | disclosed |
| US-20100047225-A1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | GENZYME CORPORATION (US) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395309-A1 | PEPTIDE-DRUG CONJUGATES | BDKRB1, VIP, BDKRB2 | FAAH 2875/4885MGLL 4358/4885TUBB4A 1772/4885 |
| US-11692022-B2 | Thiosuccinyl-crosslinked hemoglobin analogs and methods of use and preparation thereof | HBG1, HBG2, HBB | FAAH 3547/4885MGLL 2849/4885TUBB4A 2034/4885 |
| US-20150050262-A1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | MAN2B1, MAN1B1, GAA | FAAH 3163/4885MGLL 875/4885TUBB4A 1838/4885 |
| US-20170014520-A1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | MAN2B1, MAN1B1, GAA | FAAH 3163/4885MGLL 875/4885TUBB4A 1838/4885 |
| US-20210015935-A1 | HEMOGLOBIN-BASED THERAPEUTIC AGENTS | HBG1, HBG2, HBB | FAAH 4625/4885MGLL 4338/4885TUBB4A 1865/4885 |
| US-20100047225-A1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | MAN2B1, MAN1B1, GAA | FAAH 3163/4885MGLL 875/4885TUBB4A 1838/4885 |
| US-11857605-B2 | Thiosuccinyl-crosslinked hemoglobin conjugates and methods of use and preparation thereof | HBG1, HBG2, HBB | FAAH 4095/4885MGLL 3874/4885TUBB4A 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.